Wednesday, July 8, 2026

Drug profile · INN

vinblastine sulfate

vinblastine sulfate (VINBLASTINE SULFATE) is a tubulin inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — vinblastine sulfate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
2
Data quality
0.84

Quick answer

vinblastine sulfate (VINBLASTINE SULFATE) is a tubulin inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN vinblastine sulfate
Brand VINBLASTINE SULFATE
Mechanism Tubulin inhibitor
Target Tubulin
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Tubulin inhibitor

Primary target: Tubulin

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. 042011 Phase 3 · George Institute for · Langerhans Cell Histiocytosis
  2. C25003 Phase 3 · Takeda · Advanced Classical Hodgkin Lymphoma

Related & competitor drugs

  1. brentuximab vedotin Antineoplastic and immunomodulating agents (L01)
  2. cabazitaxel Antineoplastic and immunomodulating agents (L01)
  3. colchicine Musculo-skeletal system (M04)
  4. docetaxel Antineoplastic and immunomodulating agents (L01)
  5. paclitaxel Antineoplastic and immunomodulating agents (L01)
  6. vincristine sulfate Tubulin inhibitor

Frequently asked questions

What is vinblastine sulfate?

vinblastine sulfate (VINBLASTINE SULFATE) is a tubulin inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for vinblastine sulfate?

VINBLASTINE SULFATE is a marketed brand name for vinblastine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of vinblastine sulfate?

vinblastine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.